- Latest week
- 17 Jul 2026
- Close
- 9.741000
- Fair value
- 7.452628
- Next-week expectancy
- Undecided 52.78%
GNOM Chart Pack
Global X Genomics & Biotechnology UCITS ETF
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, GNOM rose 20.04%, moving from 8.12 to 9.74. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 15.29 and has improved across the 12-week window. Market Dynamics is 1.36 on the latest week. Next-week expectancy is undecided at 52.78% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 9.74
- 12-Week Change
- 20.04%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 52.78%
- Signal Weeks
- 8 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 15.29
- Market Dynamics
- 1.36
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 9.74
- 12-Week Change
- 20.04%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 52.78%
- Signal Weeks
- 8 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 15.29
- Market Dynamics
- 1.36
Over the latest 12 completed weeks ending 2026-07-17, GNOM rose 20.04%, moving from 8.12 to 9.74. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 15.29 and has improved across the 12-week window. Market Dynamics is 1.36 on the latest week. Next-week expectancy is undecided at 52.78% based on similar historical setup states.